ストックスクリーナーアプリを入手
1.97
0.00%
0.00
アフターアワーズ：
1.97
前日終値:
$1.97
開ける：
$1.95
24時間の取引高:
151.15K
Relative Volume:
0.67
時価総額：
$124.94M
収益：
$14.18M
当期純損益:
$-82.66M
株価収益率:
-1.5154
EPS:
-1.3
ネットキャッシュフロー:
$-50.80M
1週間 パフォーマンス:
-5.74%
1か月 パフォーマンス:
+4.79%
6か月 パフォーマンス:
+3.14%
1年 パフォーマンス:
+18.67%
1日の値動き範囲:
$1.95
$2.03
1週間の範囲:
$1.95
$2.15
52週間の値動き範囲:
$1.56
$2.625
Seer Inc Stock (SEER) Company Profile
SEER を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SEER
Seer Inc
|
1.97 | 124.94M | 14.18M | -82.66M | -50.80M | -1.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.52 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.49 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
595.70 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
232.75 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
229.22 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Seer Inc Stock (SEER) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-07-05 | 再開されました | JP Morgan | Neutral |
| 2023-01-04 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2022-08-11 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2020-12-29 | 開始されました | BofA Securities | Neutral |
| 2020-12-29 | 開始されました | Cowen | Outperform |
| 2020-12-29 | 開始されました | JP Morgan | Overweight |
| 2020-12-29 | 開始されました | Morgan Stanley | Equal-Weight |
すべてを表示
Seer Inc (SEER) 最新ニュース
Cadwell invests in Australian company Seer Medical - Yahoo
Cadwell Makes a Strategic Investment in Seer Medical to Expand Home-Based Epilepsy Diagnostics - Yahoo Finance
Metagenomi Leads The Charge With These 3 Penny Stocks - simplywall.st
Seer : Immuneering to Present at the 24th Annual Needham Virtual Healthcare Conference - MarketScreener
Corient Private Wealth LLC Acquires 13,200 Shares of Seer, Inc. (NASDAQ:SEER) - Defense World
SEER LAUNCHES CARBON FOCUSED DIVISION TO PRODUCE LICENSED - GlobeNewswire
SEER LAUNCHES CARBON FOCUSED DIVISION TO PRODUCE LICENSED BIOCHAR, MONETIZE AND TOKENIZE ASSETS AND CARBON CREDITS AND DEVELOP TURBINE BLADE TREATMENT TECHNOLOGY - Yahoo
After Plunging -16.59% in 4 Weeks, Here's Why the Trend Might Reverse for Seer (SEER) - MSN
After Plunging -16.81% in 4 Weeks, Here's Why the Trend Might Reverse for Seer (SEER) - Yahoo Finance
Seer, Inc. (SEER) Reports Q4 Loss, Tops Revenue Estimates - MSN
Large Tools and Labs Optimistic at TD Cowen Health Conference By Investing.com - Investing.com Australia
Large Tools and Labs Optimistic at TD Cowen Health Conference - Investing.com India
Seer Inc (SEER) Q4 2024 Earnings Report Preview: What To Look Fo - GuruFocus.com
SEER, INC. : Results of Operations and Financial Condition (form 8-K) -January 25, 2021 at 04:40 pm EST - marketscreener.com
Down -10.53% in 4 Weeks, Here's Why Seer (SEER) Looks Ripe for a Turnaround - Yahoo Finance
Y Intercept Hong Kong Ltd Acquires New Shares in Seer, Inc. (NASDAQ:SEER) - Defense World
Seer, Inc. Earnings Call: Mixed Sentiment and Optimistic Outlook - TipRanks
Seer, Inc. SEC 10-K Report - TradingView
Seer Full Year 2024 Earnings: In Line With Expectations - Yahoo Finance
Teams at Neptune Beach's Fletcher High win spots at national investment competition - MSN
Seer, Inc. (NASDAQ:SEER) Q4 2024 Earnings Call Transcript - Insider Monkey
Seer Inc (SEER) Q4 2024 Earnings Call Highlights: Navigating Rev - GuruFocus.com
Seer Inc (SEER) Q4 2024 Earnings Call Highlights: Navigating Revenue Decline with Strategic ... - Yahoo Finance
Seer, Inc. Reports 2024 Earnings and 2025 Outlook - TipRanks
Seer Inc (SEER) Q4 2024 Earnings: Revenue Beats at $4.0M, EPS Mi - GuruFocus.com
Seer Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Earnings call transcript: Seer Inc. reports Q4 2024 revenue decline, stock rises - Investing.com
Seer Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Outlook - The Manila Times
Can Seer's New Proteomics Application Drive Its Ambitious 24% Revenue Growth Target? - StockTitan
Seer To Feature Proteomic Advancements in Cancer and RNA Therapy Research Among Other Findings at US HUPO 2025 - Technology Networks
Seer Inc (SEER) Q4 2024 Earnings Report Preview: What To Look For - Yahoo Finance
Seer Inc. (SEER) Earnings Preview: Q4 2024 Revenue Expected to Decline 11% - HPBL
Monash University's Proteomics & Metabolomics Platform Strengthens Partnerships with Seer and Thermo Fisher Scientific - Monash University
Seer to Participate in the TD Cowen 45th Annual Health Care Conference - GlobeNewswire
Can Seer's Proteomics Platform Disrupt Healthcare? Management Reveals Strategy Next Week - StockTitan
Seer (SEER) Expected to Announce Quarterly Earnings on Thursday - Defense World
Seer to Feature Proteomic Advancements in Cancer and RNA - GlobeNewswire
US Penny Stocks: 3 Picks With Market Caps As Low As $70M - Simply Wall St
Seer, Inc. to Showcase Innovations in Proteomics at US HUPO 2025 Annual Conference - Nasdaq
Revolutionary Cancer Therapy Platform: How Seer's Proteomics Technology is Reshaping Treatment Research - StockTitan
Peapod Lane Capital LLC Invests $991,000 in Seer, Inc. (NASDAQ:SEER) - MarketBeat
Seer to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025 - GlobeNewswire
Seer Inc (SEER) 財務データ
収益
当期純利益
現金流量
EPS
0.15%
4.32%
大文字化:
|
ボリューム (24 時間):